跳至主要内容
临床试验/NCT04864509
NCT04864509Unknown4 期

The Effects of Melatonin Treatment on Bone, Marrow, Sleep and Blood Pressure in Post Menopausal Women

University of Aarhus0 个研究点目标入组 40 人开始时间: 2021年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
40
主要终点
Gene expression

研究概览

简要总结

Melatonin protects your bones while losing fat! This was previously demonstrated by our group. The mechanisms behind these findings are still elusive, and the aim of the present study is to assess the mechanisms.

In a double-blinded randomized controlled trial 40 postmenopausal woman are randomized to receive either 10 mg melatonin or placebo nightly for three months. Changes in gene expression in marrow cells will be assessed through micro array. Markers of bone metabolism will be assessed through biochemical markers. Cardiovascular health will be measured by tonometry and 24h blood pressure.

The results of the study will contribute with important knowledge about the beneficial effects of melatonin making it an interesting supplement to known treatment regimens against osteoporosis and overweight.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double blinded

入排标准

年龄范围
55 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Post-menopausal women between 55 and 75 years

排除标准

  • Severely impaired renal function
  • Severely impaired hepatic function
  • Coagulation factors PP<0.6
  • Hypercalcemia (p-ion calcium >1.32 nmol/l)
  • Previous or present malignancies (except a treated skin cancer that is not melanoma or treated carcinoma in situ, 2 years since last therapy)
  • Diseases affecting the calcium homeostasis including untreated thyroid diseases
  • Regular use of medicine affecting the calcium homeostasis, including diuretics, fenemal, lithium, antiepileptica and glucosteroids
  • Selective serotonin reuptake inhibitor (SSRI)-products with fluvoxamin
  • Treatment with carbamazepin
  • Treatment with rifampicin
  • Severe malabsorption syndrome including gastric or intestinal resection
  • Alcohol or drug abuse

研究组 & 干预措施

Melatonin 10mg

Active Comparator

Nightly oral dose

干预措施: Melatonin 10 MG (Drug)

Placebo

Placebo Comparator

nightly oral dose

干预措施: Placebo (Drug)

结局指标

主要结局

Gene expression

时间窗: After study completion. Up to one year

Changes in gene expression in human mesenchymal stem cells.The biopsies are put on freeze after obtaining them. All biopsies are analysed at once.

次要结局

  • Cardiovascular health(After study completion. Up to one year)
  • Biochemical markers(After study completion. Up to one year)
  • Quality of sleep(After study completion. Up to one year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验